Related Experiment Video

Updated: May 28, 2026

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

The kinetics of cell surface receptor expression in children perinatally exposed to polychlorinated biphenyls

M Horváthová1, E Jahnová, L Palkovičová

  • 1Department of Immunology and Immunotoxicology, Slovak Medical University, Bratislava, Slovakia. mira.horvathova@szu.sk

Journal of Immunotoxicology
|November 4, 2011
PubMed

Insights

Early life exposure to polychlorinated biphenyls (PCBs) significantly alters immune cell development. Infants in high-PCB areas showed altered T-lymphocyte and dendritic cell populations, indicating impaired immune system development.

Area of Science:

  • Immunology
  • Environmental Health
  • Developmental Biology

Background:

  • Polychlorinated biphenyls (PCBs) are environmental contaminants known to disrupt normal development.
  • Prenatal and early postnatal exposure to PCBs can impact immune system maturation.
  • Understanding these effects is crucial for public health, especially in contaminated regions.

Purpose of the Study:

  • To investigate the impact of environmental PCB contamination on immune cell development in infants.
  • To evaluate differences in lymphocyte and dendritic cell populations between high and low PCB exposure areas.
  • To assess the correlation between PCB exposure levels and specific immune cell markers.

Main Methods:

  • Blood samples collected from newborns, 6-month-olds, and 16-month-olds in high (Michalovce) and low (Svidnik/Stropkov) PCB contamination districts.
  • Multi-color flow cytometry used to analyze lymphocyte receptor expression.
  • Statistical analysis, including multivariate models, adjusted for covariates like maternal age, parity, and breastfeeding.

Main Results:

  • Infants in the high PCB area (Michalovce) showed increased lymphoid dendritic cells (DC) and naïve/resting T-lymphocytes at 6 months.
  • Reduced natural regulatory T-lymphocytes and suppressor inducer T-lymphocytes were observed in the high PCB area.
  • Significant differences in memory T-lymphocytes, TEM T-lymphocytes, and myeloid DC persisted between districts after covariate adjustment.

Conclusions:

  • Prenatal and early postnatal PCB exposure significantly affects the dynamics of cell surface receptor expression on immune cells.
  • These alterations suggest impaired immunologic development in infants exposed to higher levels of PCBs.
  • The findings highlight the long-term health risks associated with environmental PCB contamination during critical developmental windows.

More Related Videos

Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays08:28

Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays

Published on: April 26, 2018

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...